SBX.DE XETRA
SynBiotic SE
1W: -2.9%
1M: -15.0%
3M: -30.9%
YTD: -59.3%
1Y: -72.6%
3Y: -85.1%
5Y: -95.9%
€0.85 ($0.95)
-0.11 (-11.55%)
Weekly Expected Move ±19.2%
€1
€1
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap€4.0M ($4.5M)
52W Range0.495-3.85
Volume5,610
Avg Volume11,057
Beta0.68
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODaniel Kruse
Employees79
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-01-07
Websitesynbiotic.com
MünsterstraÃe 336
Düsseldorf, NW 40470
DE
Düsseldorf, NW 40470
DE
49 89 6003 7544
About SynBiotic SE
SynBiotic SE is dedicated to pioneering cannabinoid-based pharmaceuticals and readily available health and wellness items. Its primary strategic pillars include the laboratory synthesis of cannabinoids, advanced drug discovery, the formulation of dietary aids, and the creation of cosmetic solutions. Formerly operating as Ledgertech SE, the company is headquartered in Munich, Germany.
Latest News
No recent news
Recent Insider Trades
No insider trades found